Public record of meeting, 26 February 2018

Meeting of February 26 & 27, 2018

Lord Elgin Hotel, Ottawa

JGH

• Katie Elder
• Daniela Cortinovis

Edmonton ERSC

• Jennifer Pillay
• Lisa Hartling (via teleconference)

Ottawa ERSC

• Andrew Beck
• Julian Little
• Adrienne Stevens
• Pauline Barbeau (via teleconference)

Interns

• Geneviève Cadieux
• Amanda Ramdyal (via teleconference)

Knowledge Translation

• Sharon Straus (via teleconference)
• Danielle Kasperavicius
• Kavitha Thiyagarajah (via teleconference)

Regrets:

Heather Colquhoun (Task Force), David Moher (Ottawa ERSC), Candyce Hamel (Ottawa ERSC), Danica Buckland (SMH)

MINUTES

Day 1

1. Welcome and Introductions; Review of Action Summary and Agenda – Brett Thombs

Dr. Thombs welcomed the group to Ottawa and thanked them for their attendance. Dr. Thombs noted new faces in the room and asked everyone to introduce. Dr. Thombs then reviewed logistical items and expense forms, which will be sent out after the meeting. Dr. Thombs also announced a call for new members in the KT Working Group. Dr. Thombs asked the group if there were any concerns or action items outstanding from the October 2017 Record of Discussion (RoD) and Public Record of Discussion (PRoM). None arose. Dr. Thombs asked the group if there were any concerns or action items outstanding from the October 2017 Action Summary. None arose.

2. Osteoporosis – Guylène Thériault

Dr. Thériault presented on behalf of the Osteoporosis Working Group. The presentation reviewed progress to-date and sought feedback from Task Force members on PICOS tables, Key Questions, and outcomes.

3. Depression – Eddy Lang

Dr. Lang presented on behalf of the Depression Working Group. The presentation reviewed progress to-date and sought support from Task Force members on PICOS tables, Key Questions, and outcomes, with an additional update from the Ottawa ERSC on topic refinement.

4. New SharePoint Site – Daniela Cortinovis

Ms. Cortinovis reviewed features of the new SharePoint site and invited feedback and questions from the Task Force.

5. Social Media Update – Eddy Lang

Dr. Lang provided a brief update on social media work in the Task Force, with a focus on the anticipated launch of the Prevention PLUS site.

6. Breast Cancer Update – Scott Klarenbach

Dr. Klarenbach presented on behalf of the Breast Cancer Working Group, relaying comments from external review and outlining the expected media strategy for the guideline.

7. Knowledge Translation Update – Danielle Kasperavicius

Ms. Kasperavicius provided an update on behalf of the knowledge translation team, reviewing current KT activities underway, and invited members to comment on the Task Force’s proposed stakeholder interaction policy.

8. Grade Study – Kavitha Thiyagarajah

Ms. Thiyagarajah reviewed findings from the GRADE study, with an emphasis on clinicians’ recommended changes to guideline format and wording.

9. GRADE Implementation – Brett Thombs

Dr. Thombs led an exploratory discussion of GRADE implementation issues in the Task Force, focusing in particular on how to communicate weak recommendations.

10. Defining Primary Care – Brett Thombs

Dr. Thombs led a discussion on refinement of the Task Force definition of primary care and invited comments and recommendations.

11. Verbal Updates – Brett Thombs, Ainsley Moore, Brenda Wilson, Stéphane Groulx, Gaby Lewin

Dr. Thombs provided an update on behalf of the Thyroid Dysfunction Working Group, The systematic review is nearly finalized, and the plan is to distribute the guideline to Working Group for review in April 2018 and to the Task Force in May or June 2018. Dr. Moore provided an update on behalf of the Asymptomatic Bacteriuria Working Group, which received suggestions for only minor revisions from CMAJ. The Working Group intends to share revised guideline and abstract in early March 2018, with publication anticipated in mid-May 2018. Dr. Wilson led an update on behalf of the Visual Acuity Working Group, for which recommended changes from the publication journal have been received and incorporated into the guideline. There was one notable revision related to terminology, advising that screening for “impaired vision” is preferred over “visual acuity.” Publication is anticipated at the end of April 2018. Dr. Groulx led an update on behalf of the Esophageal Cancer Working Group, including progress underway on systematic reviews and knowledge translation activities. The Working Group hopes to present the evidence-to-decision framework at the June 2018 in-person meeting. Dr. Lewin led an update on behalf of the Diabetes Update Working Group. The Working Group is discussing options for updating guideline and will likely plan to update the 2012 systematic review, with particular attention to methods in patient values and preferences.

Day 2

12. Tobacco Cessation – Greg Traversy

Mr. Traversy presented on behalf of the Tobacco Cessation Working Group. The presentation reviewed the background and scoping exercise to-date and sought support from Task Force members on PICOS tables, Key Questions, and outcomes.

13. Chlamydia & Gonorrhea – Ainsley Moore

Dr. Moore led an update on behalf of the Chlamydia and Gonorrhea Working Group. The presentation reviewed progress to-date and sought support from Task Force members on PICOTS tables, Key Questions, and outcomes. Adjustments will be made to the guideline timeline, to accommodate revisions.

14. Debriefing about meeting with Ministère de la Santé et des Services Sociaux – Guylène Thériault

Dr. Thériault updated the group on recent meetings with the Quebec Ministry of Health on behalf of Dr. Groulx and led a discussion on paths forward.

15. GHGD Update & Guideline Timelines – Rachel Rodin

Dr. Rodin led a verbal update on behalf of the Global Health and Guidelines Division, reviewing guideline timelines and staffing changes.

16. Next Steps and Adjournment – Brett Thombs

Dr. Thombs thanked the group for their attendance and once again welcomed new members to the team. He reminded the Task Force to please send expense receipts to the Task Force Administrators. Dates for the next meeting are June 4-5, and the location is again at the Lord Elgin Hotel in Ottawa.